Calphostin C at 10(-6) M was shown to be selective and highly effective in inhibiting contractile responses of rat aortae to 12-o-tetradecanoylphorbol-13-acetate, while it had no effect on contractile responses to elevated KCl. 2. In the rat aorta, endothelin-1 (ET-1) developed a sustained tonic contraction dose-dependently in both normal Ca(2+)-containing Krebs and Ca(2+)-free Krebs containing 1 mM EGTA. Calphostin C (10(-6) M), a selective protein kinase C inhibitor, antagonized the maximal tensions for cumulative addition of 10(-8) M ET-1 by 13.2% in Ca(2+)-containing medium and 25.8% in Ca(2+)-free Krebs containing 1 mM EGTA. 3. In both Ca(2+)-containing medium and Ca(2+)-free Krebs containing 1 mM EGTA, precontraction with 10(-8) M ET-1 had no effects on the contractile response to subsequently added 10(-6) M 12-o-tetradecanoylphorbol-13-acetate (TPA), an activator of protein kinase C. 4. In Ca(2+)-free Krebs containing 1 mM EGTA, precontraction with 10(-6) M TPA potentiated the contractile response to subsequently added 10(-8) M ET-1, whereas this potentiation was abolished by pretreatment with 10(-6) M calphostin C. The mechanism of the TPA-induced potentiating effect remains to be determined. 5. These results suggest that the participation of protein kinase C in the 10(-8) M ET-1-induced contraction may be 13.2% and 25.8% in the presence and absence of extracellular Ca2+, respectively, and that mechanisms other than protein kinase C may be predominantly responsible for ET-1-induced tonic contraction.
摘要
已证明10⁻⁶ M的钙泊三醇C具有选择性且能高效抑制大鼠主动脉对12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯的收缩反应,而对高钾氯化钾引起的收缩反应无影响。2. 在大鼠主动脉中,内皮素 - 1(ET - 1)在含正常钙的Krebs液和含1 mM乙二醇双四乙酸(EGTA)的无钙Krebs液中均呈剂量依赖性地产生持续的强直性收缩。钙泊三醇C(10⁻⁶ M),一种选择性蛋白激酶C抑制剂,在含钙介质中使累积添加10⁻⁸ M ET - 1时的最大张力拮抗了13.2%,在含1 mM EGTA的无钙Krebs液中拮抗了25.8%。3. 在含钙介质和含1 mM EGTA的无钙Krebs液中,用10⁻⁸ M ET - 1预收缩对随后添加的10⁻⁶ M 12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA,一种蛋白激酶C激活剂)的收缩反应均无影响。4. 在含1 mM EGTA的无钙Krebs液中,用10⁻⁶ M TPA预收缩增强了对随后添加的10⁻⁸ M ET - 1的收缩反应,而这种增强作用被用10⁻⁶ M钙泊三醇C预处理所消除。TPA诱导的增强作用机制尚待确定。5. 这些结果表明,在有和无细胞外钙离子存在的情况下,蛋白激酶C参与10⁻⁸ M ET - 1诱导的收缩作用可能分别为13.2%和25.8%,并且除蛋白激酶C之外的其他机制可能是ET - 1诱导强直性收缩的主要原因。